Back to Search Start Over

Persistent atrial fibrillation presenting in sinus rhythm: pulmonary vein isolation versus pulmonary vein isolation plus electrogram-guided ablation.

Authors :
Sebag FA
Chaachoui N
Linton NW
Amraoui S
Harrison J
Williams S
Rinaldi AC
Gill J
Cooklin M
Kirubakaran S
O'Neill MD
Wright M
Lellouche N
Source :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2013 Oct; Vol. 106 (10), pp. 501-10. Date of Electronic Publication: 2013 Sep 23.
Publication Year :
2013

Abstract

Background: The classification of atrial fibrillation as paroxysmal or persistent (PsAF) is clinically useful, but does not accurately reflect the underlying pathophysiology and is therefore a suboptimal guide to selection of ablation strategy.<br />Aim: To determine if additional substrate ablation is beneficial for a subset of patients with PsAF, in whom long periods of sinus rhythm (SR) can be maintained.<br />Methods: We included patients presenting with PsAF in whom continuous periods of SR>3months were documented. All patients were in SR on the day of the procedure. Electrical pulmonary vein isolation (PVI) was performed in all patients. Additional electrogram (EGM)-guided ablation was left to the discretion of the operator. Patient characteristics and follow-up were analysed with respect to presence or absence of additional EGM-guided ablation.<br />Results: Sixty-five patients (mean age 60.1±8.9years; 81.5% men) met the inclusion criteria. EGM-guided ablation was performed in 32 (49%) patients. Patients with and without EGM-guided ablation had similar baseline characteristics. Absence of EGM-guided ablation was one of the independent predictors for arrhythmia recurrences after the index procedure (hazard ratio 0.24; confidence interval 0.12-0.47). After a median follow-up of 18±10months, the number of procedures required was significantly higher in the 'PVI-only' group (2.24±0.75 vs. 1.84±0.81; P=0.04) to achieve a similar success rate (84% vs. 81%; P=0.833).<br />Conclusion: The addition of EGM-guided ablation requires fewer procedures to achieve similar clinical efficacy in mid-term follow-up compared with a PVI-only strategy in patients with PsAF presenting for ablation in SR.<br /> (Copyright © 2013. Published by Elsevier Masson SAS.)

Details

Language :
English
ISSN :
1875-2128
Volume :
106
Issue :
10
Database :
MEDLINE
Journal :
Archives of cardiovascular diseases
Publication Type :
Academic Journal
Accession number :
24070597
Full Text :
https://doi.org/10.1016/j.acvd.2013.06.048